hotspot -WSS

hotspot

author：fashion 2025-09-27 23:33:25 - browse：4

Photograph of an abandoned lab with empty bottle, boxes, and beakers all around. -- biotech coverage from STAT — Adobe

SAN DIEGO — It was spring 2020, and Histogen, a small biotech with big ambitions to regenerate tissues throughout the body and turn a profit in the process, had just gone public. The company’s leadership believed they were poised for success — until everything slowly and irreversibly fell apart.

Three years later, Histogen no longer develops therapies. It has abandoned efforts to reverse baldness, replenish cartilage in achy knees, and quell infection and inflammation.

The company has no lab. It has no headquarters. It has just two employees, including a chief financial officer who also serves as secretary, CEO, and president. Histogen’s stock trades below $1 a share. And even that is coming to a close. On Thursday, the Nasdaq suspended trading of Histogen shares after determining that the company’s operations and assets are negligible, meaning the biotech is now officially a shell of its former self.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Psychedelics group wrestles with new pharma identity
Next article： Medtronic CEO on promising devices for diabetes, hypertension

focus

WSS

Anxious about a speech? A startup wants you to pop a minty cardiac drug

Criminal prosecution for violating HIPAA: an emerging threat

Eli Lilly to pay $200M for Beam’s stake in gene

Readout Newsletter: The latest from Bristol, Sarepta, and Novartis

Meta's Zuckerberg and Chan on track to put $50 billion into science

FDA has safety concerns on CRISPR

Wikipedia

hotspot

knowledge

Apple is now the first public company to be valued at $3 trillion

Microsoft's Peter Lee says ChatGPT shouldn't be used for initial diagnosis

Walensky prepares to leave CDC — and Congress — behind

Wearables generate powerful data but its not useful to doctors, yet

Drug repurposing or repositioning? The language matters

Testing for cancer recurrence creates a new limbo for patients

New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

Readout LOUD podcast: Live from STAT Breakthrough Summit West

New air purifier tech could be key to improving indoor air quality

Why Sanofi got shellacked over its spinoff

hotspot

Senate panel to vote on hospitals, PBMs, prisoner care

Meta's Zuckerberg and Chan on track to put $50 billion into science

Solving academic medical centers' existential crisis

Biden's order seeks to regulate AI risk without stifling innovation

The Readout: Lisata, Eisai x Biogen, and the Met Gala (!)

Paying for Covid pills will soon shift to insurers

entertainment

hotspot

focus

hotspot